Tracy Hays
Obstetrics & Gynecology · Dallas, TXNPI 1528064730
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.2%), consulting fees and education — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Mimedx Group, Inc. at 49.1% of the total. 2025 is the largest year on record at $2,138, 7.6 times the $283 reported in 2019.
Across 174 payments — averaging $35.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$3K
- AbbVie$988
- Exeltis, USA Inc.$268
- Mayne Pharma Commercial LLC$204
- Organon$175
- Millicent US Inc$144
- plus $1K from 26 others
What the payments were for
- Consulting fees$3,00049%
- Food & beverage$3,06450%
- Education$431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 11 | $3,000 |
| AbbVie(2 entities) | 55 | $988 |
| Exeltis, USA Inc. | 18 | $268 |
| Mayne Pharma Commercial LLC | 8 | $204 |
| Organon | 7 | $175 |
| Millicent US Inc | 7 | $144 |
| Therapeuticsmd, Inc. | 9 | $137 |
| Shield Therapeutics Inc | 3 | $118 |
| Sumitomo Pharma America, Inc. | 4 | $104 |
| Astellas Pharma US Inc | 5 | $90 |
| Pfizer | 4 | $79 |
| Myriad Women's Health, Inc. | 1 | $69 |
| Myovant Sciences Inc. | 4 | $68 |
| Merck | 5 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Exact Sciences | 2 | $48 |
| Bayer | 2 | $46 |
| Avion Pharmaceuticals | 3 | $45 |
| AMAG Pharmaceuticals, Inc. | 3 | $43 |
| Agile Therapeutics, Inc. | 3 | $42 |
| Evofem Biosciences, Inc. | 2 | $41 |
| Sage Therapeutics, LLC | 2 | $34 |
| Meditrina | 1 | $31 |
| Virtus Pharmaceuticals LLC | 2 | $29 |
| Duchesnay USA Incorporated | 2 | $25 |
| Acessa Health Inc. | 2 | $25 |
| Gynesonics, Inc. | 1 | $20 |
| Minerva Surgical, Inc | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Coopersurgical, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOVINE COLLAGEN$400
How this compares
$6,107 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 13 | $786 |
| Estradiol | 12 | $585 |
| ProgesteroneProgesterone, Micronized | 19 | $513 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Dallas
- Dale StovallDallas$590K
- Quanita CrableDallas$176K
- Kamilia SmithDallas$119K
- Yolanda LawsonDallas$96K
- Patrick WeixDallas$96K
- David RogersDallas$44K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.